chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: her patient received three doses of Moderna Covid19 Vaccine; three doses of Moderna Covid19 Vaccine on 05Feb2021,12Apr2021and 11May2021; This spontaneous case was reported by a health care professional and describes the occurrence of EXTRA DOSE ADMINISTERED (her patient received three doses of Moderna Covid19 Vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (three doses of Moderna Covid19 Vaccine on 05Feb2021,12Apr2021and 11May2021) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043l20a) for COVID-19 vaccination.     No medical history was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-May-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (her patient received three doses of Moderna Covid19 Vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (three doses of Moderna Covid19 Vaccine on 05Feb2021,12Apr2021and 11May2021). At the time of the report, EXTRA DOSE ADMINISTERED (her patient received three doses of Moderna Covid19 Vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (three doses of Moderna Covid19 Vaccine on 05Feb2021,12Apr2021and 11May2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided. No Treatment information was  provided.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Product administration error
Clinical narrative: Vaccine Administration Error (Invalid Dose; Off-Label Use); administration of the Moderna COVID-19 Vaccine to a 17 year old male; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Vaccine Administration Error (Invalid Dose; Off-Label Use)) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administration of the Moderna COVID-19 Vaccine to a 17 year old male) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Vaccine Administration Error (Invalid Dose; Off-Label Use)) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administration of the Moderna COVID-19 Vaccine to a 17 year old male). On 17-May-2021, PRODUCT ADMINISTRATION ERROR (Vaccine Administration Error (Invalid Dose; Off-Label Use)) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administration of the Moderna COVID-19 Vaccine to a 17 year old male) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Pain in extremity
Clinical narrative: Really bad hand pain/ Someone hitting hands with hammer; felt an excruciating amount of pain; very bad pain in her hands and joints; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Really bad hand pain/ Someone hitting hands with hammer), PAIN (felt an excruciating amount of pain) and ARTHRALGIA (very bad pain in her hands and joints) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, the patient experienced PAIN IN EXTREMITY (Really bad hand pain/ Someone hitting hands with hammer), PAIN (felt an excruciating amount of pain) and ARTHRALGIA (very bad pain in her hands and joints). On 15-May-2021, PAIN IN EXTREMITY (Really bad hand pain/ Someone hitting hands with hammer), PAIN (felt an excruciating amount of pain) and ARTHRALGIA (very bad pain in her hands and joints) had resolved.            No concomitant products were reported. Treatment information provided included Ibuprofen. But the patient is not sure that she had taken it. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-049572.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Caller also received 2nd dose and no side effects other than sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Caller also received 2nd dose and no side effects other than sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Caller also received 2nd dose and no side effects other than sore arm). At the time of the report, VACCINATION SITE PAIN (Caller also received 2nd dose and no side effects other than sore arm) outcome was unknown.            No concomitant products were reported.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-041170 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Administered Moderna Covid-19; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Administered Moderna Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Administered Moderna Covid-19). On 24-Apr-2021, INTERCHANGE OF VACCINE PRODUCTS (Administered Moderna Covid-19) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information not provided. Treatment medication information not provided .
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath; This spontaneous case was reported by a physician and describes the occurrence of DYSPNOEA (Shortness of breath) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Polymyalgia rheumatica. Concomitant products included LEVOTHYROXINE for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSPNOEA (Shortness of breath). The patient was treated with PREDNISONE for Shortness of breath, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  Patient consequently had pulmonary and cardio clearance and everything was normal.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Possible adverse event of administering invalid dose to patients.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of INCORRECT DOSE ADMINISTERED (Possible adverse event of administering invalid dose to patients.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Possible adverse event of administering invalid dose to patients.). At the time of the report, INCORRECT DOSE ADMINISTERED (Possible adverse event of administering invalid dose to patients.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Injection site pain, Lethargy, Limb discomfort
Clinical narrative: very sore arm at injection site; very large/swollen lymph node; ache in my right breast/armpit; ache in my right breast/armpit; body aches; My limbs felt so heavy I wasn't able to lift them off the bed; Lethargy; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), AXILLARY PAIN (ache in my right breast/armpit), LIMB DISCOMFORT (My limbs felt so heavy I wasn't able to lift them off the bed), BREAST PAIN (ache in my right breast/armpit) and MYALGIA (body aches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  The patient's past medical history included Anemia (Border line iron deficiency anemia.) in 2017. Concomitant products included IRON EXTRA for Iron deficiency, COLECALCIFEROL, FISH OIL (FISH OIL PLUS VITAMIN D) for an unknown indication.  On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021 at 11:20 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced AXILLARY PAIN (ache in my right breast/armpit), BREAST PAIN (ache in my right breast/armpit) and LYMPHADENOPATHY (very large/swollen lymph node). On an unknown date, the patient experienced LETHARGY (Lethargy), LIMB DISCOMFORT (My limbs felt so heavy I wasn't able to lift them off the bed), MYALGIA (body aches) and INJECTION SITE PAIN (very sore arm at injection site). At the time of the report, LETHARGY (Lethargy), LIMB DISCOMFORT (My limbs felt so heavy I wasn't able to lift them off the bed) and MYALGIA (body aches) had resolved, AXILLARY PAIN (ache in my right breast/armpit), BREAST PAIN (ache in my right breast/armpit) and LYMPHADENOPATHY (very large/swollen lymph node) had not resolved and INJECTION SITE PAIN (very sore arm at injection site) outcome was unknown.     The other concomitants include Thyroid PX for hypothyroidism from 2017, DIMension 3 for estrogen metabolism from 2017, RegeneMax Plus for collagen generator from 2019 taken daily by oral route. No treatment was reported.  This case was linked to US-MODERNATX, INC.-MOD-2021-078457 (E2B Linked Report). This case was linked to MOD-2021-078457 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-078457:Dose 1
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia
Clinical narrative: very sore arm at injection site; very large/swollen lymph node; ache in my right breast/armpit; ache in my right breast/armpit; body aches; My limbs felt so heavy I wasn't able to lift them off the bed; Lethargy; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), AXILLARY PAIN (ache in my right breast/armpit), LIMB DISCOMFORT (My limbs felt so heavy I wasn't able to lift them off the bed), BREAST PAIN (ache in my right breast/armpit) and MYALGIA (body aches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  The patient's past medical history included Anemia (Border line iron deficiency anemia.) in 2017. Concomitant products included IRON EXTRA for Iron deficiency, COLECALCIFEROL, FISH OIL (FISH OIL PLUS VITAMIN D) for an unknown indication.  On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021 at 11:20 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced AXILLARY PAIN (ache in my right breast/armpit), BREAST PAIN (ache in my right breast/armpit) and LYMPHADENOPATHY (very large/swollen lymph node). On an unknown date, the patient experienced LETHARGY (Lethargy), LIMB DISCOMFORT (My limbs felt so heavy I wasn't able to lift them off the bed), MYALGIA (body aches) and INJECTION SITE PAIN (very sore arm at injection site). At the time of the report, LETHARGY (Lethargy), LIMB DISCOMFORT (My limbs felt so heavy I wasn't able to lift them off the bed) and MYALGIA (body aches) had resolved, AXILLARY PAIN (ache in my right breast/armpit), BREAST PAIN (ache in my right breast/armpit) and LYMPHADENOPATHY (very large/swollen lymph node) had not resolved and INJECTION SITE PAIN (very sore arm at injection site) outcome was unknown.     The other concomitants include Thyroid PX for hypothyroidism from 2017, DIMension 3 for estrogen metabolism from 2017, RegeneMax Plus for collagen generator from 2019 taken daily by oral route. No treatment was reported.  This case was linked to US-MODERNATX, INC.-MOD-2021-078457 (E2B Linked Report). This case was linked to MOD-2021-078457 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-078457:Dose 1
Age: 62.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: covid arm; This spontaneous case was reported by a consumer and describes the occurrence of   in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Migraine. Concomitant products included SUMATRIPTAN (IMITREX [SUMATRIPTAN]) from an unknown date to 11-Mar-2021 for Migraine.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment medication was not reported.   This case was linked to MOD-2021-143721 (Patient Link).
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Mobility decreased, Pyrexia
Clinical narrative: felt I couldnt move; Fever; chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-May-2021 and was forwarded to Moderna on 18-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (felt I couldnt move), PYREXIA (Fever) and CHILLS (chills) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Migraine. Previously administered products included for an unreported indication: IMITREX DF.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced MOBILITY DECREASED (felt I couldnt move), PYREXIA (Fever) and CHILLS (chills). At the time of the report, MOBILITY DECREASED (felt I couldnt move), PYREXIA (Fever) and CHILLS (chills) had resolved.            Action taken with mRNA-1273 in response to the drug was not applicable. No concomitant medication information was provided. No treatment medication information was provided    This case was linked to MOD-2021-143665 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: It is almost 6 months now from her first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It is almost 6 months now from her first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (It is almost 6 months now from her first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It is almost 6 months now from her first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment was reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: starting to feel aches in hands, wrists, fingers; starting to feel aches in hands, wrists, fingers; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (starting to feel aches in hands, wrists, fingers) and ARTHRALGIA (starting to feel aches in hands, wrists, fingers) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Rheumatoid arthritis.    On 29-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (starting to feel aches in hands, wrists, fingers) and ARTHRALGIA (starting to feel aches in hands, wrists, fingers). At the time of the report, PAIN IN EXTREMITY (starting to feel aches in hands, wrists, fingers) and ARTHRALGIA (starting to feel aches in hands, wrists, fingers) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medicines were not provided,   Action taken with mRNA-1273 in response to the event was unknown.   Reporter did not allow further contact
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Pyrexia, SARS-CoV-2 test
Clinical narrative: Consistent Cough; Fever; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Consistent Cough) and PYREXIA (Fever) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004B21A) for COVID-19 vaccination.     Concomitant products included PHENYTOIN (DILANTIN [PHENYTOIN]), LOSARTAN, MEMANTINE, BRIMONIDINE and POLYCARBOPHIL CALCIUM (FIBER) for an unknown indication.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (Consistent Cough) and PYREXIA (Fever). The patient was treated with GUAIFENESIN (MUCINEX) at an unspecified dose and frequency; ZINC at an unspecified dose and frequency; ASCORBIC ACID (VITAMINS C) at an unspecified dose and frequency and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) at an unspecified dose and frequency. At the time of the report, COUGH (Consistent Cough) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-May-2021, SARS-CoV-2 test: positive positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other relevant concomitant medication included Mulit Vitamins.  Treatment information included CPACK Citromiacin for 5 days.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, based on the mechanism of action of mRNA-1273, causal association between the event of COVID-19 infection  and mRNA-1273 is assessed as not applicable.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Really bad muscle pain after 1st dose; Really bad joint pain after 1st dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-May-2021 and was forwarded to Moderna on 18-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Really bad muscle pain after 1st dose) and ARTHRALGIA (Really bad joint pain after 1st dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025a21a and 028a21a) for COVID-19 vaccination.     Concurrent medical conditions included COPD and Chronic bronchitis.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Really bad muscle pain after 1st dose) and ARTHRALGIA (Really bad joint pain after 1st dose). The patient was treated with IBUPROFEN (ADVIL 12HOUR) for Pain, at an unspecified dose and frequency. At the time of the report, MYALGIA (Really bad muscle pain after 1st dose) and ARTHRALGIA (Really bad joint pain after 1st dose) outcome was unknown.          concomitant product details not provided. Patient  received the 1st dose of the Moderna COVID-19 vaccine on 26Feb2021. She says that within a week she had really bad muscle and joint pain. patient  says the pain was still there by the time of the 2nd dose on 26Mar2021. and the pain was unrelenting and very severe and it keeps her up at night.patient last saw her doctor almost a month ago and the doctor suggested to call to report the pain. patient  has been tested for inflammation and there is no inflammation on the blood tests. She says the pain went from a 1 to 2/10 to 8/10 after the vaccine. She says she is on Advil constantly.   patient  also mentions that she has COPD and chronic bronchitis and that at about the same time the joint pain began, her lungs seemed to feel better. She says her lungs are more flexible after the vaccine.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (fever) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported. On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Polymerase chain reaction
Clinical narrative: COVID-19; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Polymerase chain reaction: (Positive) COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Treatment information was not provided
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Needle issue
Clinical narrative: Only 1" needles were available for the following 4 MERCE COVID-19 immunization clinics and 1 booster clinic documented on the Navigator site:; This spontaneous case was reported by an other health care professional and describes the occurrence of NEEDLE ISSUE (Only 1" needles were available for the following 4 MERCE COVID-19 immunization clinics and 1 booster clinic documented on the Navigator site:) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced NEEDLE ISSUE (Only 1" needles were available for the following 4 MERCE COVID-19 immunization clinics and 1 booster clinic documented on the Navigator site:). At the time of the report, NEEDLE ISSUE (Only 1" needles were available for the following 4 MERCE COVID-19 immunization clinics and 1 booster clinic documented on the Navigator site:) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments.   No concomitant medication provided by the reporter no treatment information reported by the reporter
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Neck pain, SARS-CoV-2 test
Clinical narrative: Back pain; Neck pain; Shoulder Pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-May-2021 and was forwarded to Moderna on 17-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), NECK PAIN (Neck pain) and ARTHRALGIA (Shoulder Pain) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 009C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 14-Dec-2020. Concurrent medical conditions included Drug allergy (aspirin). Concomitant products included VITAMIN B12 NOS and VITAMIN D3 for Blood test, FISH OIL for an unknown indication.   On 17-Apr-2021 at 6:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 13-May-2021 at 9:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 13-May-2021, the patient experienced BACK PAIN (Back pain), NECK PAIN (Neck pain) and ARTHRALGIA (Shoulder Pain). On 16-May-2021, BACK PAIN (Back pain), NECK PAIN (Neck pain) and ARTHRALGIA (Shoulder Pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Dec-2020, SARS-CoV-2 test: positive Positive.         The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No treatment reported.    This case was linked to MOD-2021-080111 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever). On 14-Feb-2021, PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, SARS-CoV-2 antibody test: negative (Negative) Patient has undergone antibody test which was negative.         No relevant concomitant medications were reported.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: no spike protein based on lab test; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (no spike protein based on lab test) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 004M20A) for COVID-19 vaccination.     No medical history were reported. .    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (no spike protein based on lab test). At the time of the report, VACCINATION COMPLICATION (no spike protein based on lab test) outcome was unknown.            Patient started T-CHOP chemo on 26-Feb-2021. concomitant medications were not given . Treatment information were not provided. No lab data has been provided by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Middle insomnia, Myalgia, Therapeutic response unexpected
Clinical narrative: At about the same time the joint pain began, her lungs seemed to feel better. She says her lungs are more flexible after the vaccine; Pain keeps her up at night after 2nd dose; Unrelenting pain after 2nd dose / Very severe pain after 2nd dose / Pain 8/10 after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (At about the same time the joint pain began, her lungs seemed to feel better. She says her lungs are more flexible after the vaccine), MIDDLE INSOMNIA (Pain keeps her up at night after 2nd dose) and MYALGIA (Unrelenting pain after 2nd dose / Very severe pain after 2nd dose / Pain 8/10 after the vaccine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028a21a) for COVID-19 vaccination.     Concurrent medical conditions included COPD and Chronic bronchitis.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (At about the same time the joint pain began, her lungs seemed to feel better. She says her lungs are more flexible after the vaccine), MIDDLE INSOMNIA (Pain keeps her up at night after 2nd dose) and MYALGIA (Unrelenting pain after 2nd dose / Very severe pain after 2nd dose / Pain 8/10 after the vaccine). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (At about the same time the joint pain began, her lungs seemed to feel better. She says her lungs are more flexible after the vaccine), MIDDLE INSOMNIA (Pain keeps her up at night after 2nd dose) and MYALGIA (Unrelenting pain after 2nd dose / Very severe pain after 2nd dose / Pain 8/10 after the vaccine) outcome was unknown.            No relevant concomitant medications were reported.   This case was linked to MOD-2021-143837 (Patient Link).
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Fatigue, Hyperhidrosis, Pain in extremity
Clinical narrative: chest pain (pain scale 6-7); sweating; hard breathing; pain in arms; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain (pain scale 6-7)), HYPERHIDROSIS (sweating), DYSPNOEA (hard breathing), FATIGUE (fatigue) and PAIN IN EXTREMITY (pain in arms) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022V21A or 02ZVZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced HYPERHIDROSIS (sweating), DYSPNOEA (hard breathing), FATIGUE (fatigue) and PAIN IN EXTREMITY (pain in arms). On an unknown date, the patient experienced CHEST PAIN (chest pain (pain scale 6-7)). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN 81) at an unspecified dose and frequency. At the time of the report, CHEST PAIN (chest pain (pain scale 6-7)), HYPERHIDROSIS (sweating), DYSPNOEA (hard breathing), FATIGUE (fatigue) and PAIN IN EXTREMITY (pain in arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: Threw up; Diarrhea; literally defecated water while standing up showering; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea; literally defecated water while standing up showering) and VOMITING (Threw up) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, the patient experienced DIARRHOEA (Diarrhea; literally defecated water while standing up showering). On 19-May-2021, the patient experienced VOMITING (Threw up). At the time of the report, DIARRHOEA (Diarrhea; literally defecated water while standing up showering) had resolved and VOMITING (Threw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications or treatment details provided. Patient was concerned whether to take 2nd dose or not.   This case was linked to MOD-2021-225646, MOD-2021-225646 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Event(vomiting) was added. On 24-May-2021: Follow-up information received on 24-MAY-2021 contains non-significant information. On 17-Jun-2021: Initial Additional-1 : 2nd dose and AE details On 23-Jun-2021: date of events diarrhea and threw up occurred and outcome of event updated. On 23-Jun-2021: batch number added.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Pain in extremity
Clinical narrative: Threw up; Diarrhea; literally defecated water while standing up showering; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea; literally defecated water while standing up showering) and VOMITING (Threw up) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, the patient experienced DIARRHOEA (Diarrhea; literally defecated water while standing up showering). On 19-May-2021, the patient experienced VOMITING (Threw up). At the time of the report, DIARRHOEA (Diarrhea; literally defecated water while standing up showering) had resolved and VOMITING (Threw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications or treatment details provided. Patient was concerned whether to take 2nd dose or not.   This case was linked to MOD-2021-225646, MOD-2021-225646 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Event(vomiting) was added. On 24-May-2021: Follow-up information received on 24-MAY-2021 contains non-significant information. On 17-Jun-2021: Initial Additional-1 : 2nd dose and AE details On 23-Jun-2021: date of events diarrhea and threw up occurred and outcome of event updated. On 23-Jun-2021: batch number added.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bedridden, Dizziness, Fatigue, Illness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (extreme dizziness/ dizziness bad after second shot), TRIGEMINAL NEURALGIA (extremely intense Trigeminal Neuralgic pain over the right side of the face/exacerbation of my neurological disorder), ILLNESS (I am completely sick, since 8 days ago), TINNITUS (severe ringing in my ears) and BEDRIDDEN (have been in bed every day) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below. No medical history was reported by the reporter. Concomitant products included TOPIRAMATE (TOPAMAX), GABAPENTIN, CARBAMAZEPINE (TEGRETOL), OXYCODONE and OXYCODONE HYDROCHLORIDE (OXYCONTIN) for an unknown indication. On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 10-May-2021, the patient experienced DIZZINESS (extreme dizziness/ dizziness bad after second shot), TRIGEMINAL NEURALGIA (extremely intense Trigeminal Neuralgic pain over the right side of the face/exacerbation of my neurological disorder), ILLNESS (I am completely sick, since 8 days ago) and FATIGUE (I am tired too). On an unknown date, the patient experienced TINNITUS (severe ringing in my ears), BEDRIDDEN (have been in bed every day) and ASTHENIA (NO ENERGY). The patient was treated with MECLIZINE HCL for Dizziness, at a dose of UNK dosage form. At the time of the report, DIZZINESS (extreme dizziness/ dizziness bad after second shot), TRIGEMINAL NEURALGIA (extremely intense Trigeminal Neuralgic pain over the right side of the face/exacerbation of my neurological disorder), ILLNESS (I am completely sick, since 8 days ago), TINNITUS (severe ringing in my ears), BEDRIDDEN (have been in bed every day), ASTHENIA (NO ENERGY) and FATIGUE (I am tired too) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. This case was linked to MOD21-083491, MOD21-083504 (E2B Linked Report). This case was linked to MOD-2021-094655. Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: New events-Severe ringing in ears, have been bed every day and  No energy was updated.; Sender's Comments: MOD21-083491:MOD21-083504:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Trigeminal neuralgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (extreme dizziness/ dizziness bad after second shot), TRIGEMINAL NEURALGIA (extremely intense Trigeminal Neuralgic pain over the right side of the face/exacerbation of my neurological disorder), ILLNESS (I am completely sick, since 8 days ago), TINNITUS (severe ringing in my ears) and BEDRIDDEN (have been in bed every day) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below. No medical history was reported by the reporter. Concomitant products included TOPIRAMATE (TOPAMAX), GABAPENTIN, CARBAMAZEPINE (TEGRETOL), OXYCODONE and OXYCODONE HYDROCHLORIDE (OXYCONTIN) for an unknown indication. On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 10-May-2021, the patient experienced DIZZINESS (extreme dizziness/ dizziness bad after second shot), TRIGEMINAL NEURALGIA (extremely intense Trigeminal Neuralgic pain over the right side of the face/exacerbation of my neurological disorder), ILLNESS (I am completely sick, since 8 days ago) and FATIGUE (I am tired too). On an unknown date, the patient experienced TINNITUS (severe ringing in my ears), BEDRIDDEN (have been in bed every day) and ASTHENIA (NO ENERGY). The patient was treated with MECLIZINE HCL for Dizziness, at a dose of UNK dosage form. At the time of the report, DIZZINESS (extreme dizziness/ dizziness bad after second shot), TRIGEMINAL NEURALGIA (extremely intense Trigeminal Neuralgic pain over the right side of the face/exacerbation of my neurological disorder), ILLNESS (I am completely sick, since 8 days ago), TINNITUS (severe ringing in my ears), BEDRIDDEN (have been in bed every day), ASTHENIA (NO ENERGY) and FATIGUE (I am tired too) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. This case was linked to MOD21-083491, MOD21-083504 (E2B Linked Report). This case was linked to MOD-2021-094655. Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: New events-Severe ringing in ears, have been bed every day and  No energy was updated.; Sender's Comments: MOD21-083491:MOD21-083504:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Antibody test negative
Clinical narrative: No antibodies; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (No antibodies) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Granulomatosis with polyangiitis. Concomitant products included RITUXIMAB (RITUXAN) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced ANTIBODY TEST NEGATIVE (No antibodies). At the time of the report, ANTIBODY TEST NEGATIVE (No antibodies) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-May-2021, Antibody test: no antibodies (Negative) No antibodies.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment information provided.  Company Comment : Patient is on concomitant therapy with RITUXIMAB which has been found to reduce the serological response and effectiveness of COVID vaccines as such causal relationship cannot be excluded.; Sender's Comments: Patient is on concomitant therapy with RITUXIMAB which has been found to reduce the serological response and effectiveness of COVID vaccines as such causal relationship cannot be excluded.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Gait disturbance, Influenza like illness, Pelvic pain, Urticaria
Clinical narrative: Horrendous hives that spread all over body; she was having difficulty walking or turning around; Flu like symptoms; Diarrhea; Severe pelvic pain; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), DIARRHOEA (Diarrhea), PELVIC PAIN (Severe pelvic pain), URTICARIA (Horrendous hives that spread all over body) and GAIT DISTURBANCE (she was having difficulty walking or turning around) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder and Insomnia. Concomitant products included LORAZEPAM (ATIVAN) for Insomnia, IBUPROFEN (ADVIL [IBUPROFEN]) and PARACETAMOL (TYLENOL) for an unknown indication.    On 18-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). 18-Apr-2021, the patient experienced DIARRHOEA (Diarrhea) and PELVIC PAIN (Severe pelvic pain). On an unknown date, the patient experienced URTICARIA (Horrendous hives that spread all over body) and GAIT DISTURBANCE (she was having difficulty walking or turning around). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), DIARRHOEA (Diarrhea), PELVIC PAIN (Severe pelvic pain), URTICARIA (Horrendous hives that spread all over body) and GAIT DISTURBANCE (she was having difficulty walking or turning around) outcome was unknown.            Treatment  also included: steroidal cream.
Sex: U
Vaccine: COVID19
Symptoms: Atrial flutter
Clinical narrative: Atrial flutter; This spontaneous case was reported by a consumer and describes the occurrence of ATRIAL FLUTTER (Atrial flutter) in a not specif patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ATRIAL FLUTTER (Atrial flutter). At the time of the report, ATRIAL FLUTTER (Atrial flutter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Neurological symptom
Clinical narrative: Neurological Symptoms; This spontaneous case was reported by a non-health professional and describes the occurrence of NEUROLOGICAL SYMPTOM (Neurological Symptoms) in a male patient of an unknown age who received mRNA-1273 for COVID-19 vaccination.     Medical history and concomitant medication was not provided.     On an unknown date, the patient received second dose of mRNA-1273 (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced NEUROLOGICAL SYMPTOM (Neurological Symptoms). At the time of the report, NEUROLOGICAL SYMPTOM (Neurological Symptoms) outcome was unknown.            The action taken with the drug in response to the event(s) was not applicable.